These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2787541)

  • 21. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoactivation of human plasma prekallikrein.
    Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
    J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Part of prekallikrein removed from human plasma together with IgG--immunoblot experiments and functional tests.
    Briseid K; Hoem NO; Johannesen S
    Scand J Clin Lab Invest; 1999 Feb; 59(1):55-63. PubMed ID: 10206098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on synthetic peptide substrates for F XII enzymes.
    Friberger P; Aurell L; Rees W; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():53-61. PubMed ID: 3643740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.
    Mitropoulos KA
    Thromb Res; 1999 Apr; 94(2):117-29. PubMed ID: 10230897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.